approval
saveEPYSQLI (ECULIZUMAB-AAGH) — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTION. Route: SOLUTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 23, 2026 · 254d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 28, 2025 · 310d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalSep 2, 2025 · 397d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalApr 30, 2025 · 522d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalMar 12, 2025 · 571d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 28, 2025 · 614d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 21, 2025 · 621d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 15, 2024 · 688d ago
same company · ±60 days · 6
- approvalBYOOVIZ: BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalNov 12, 2025
- recallSamsung Bioepis Co., Ltd. recall (Cls II)Nov 5, 2025
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalNov 18, 2025
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalNov 18, 2025
- approvaldenosumab biosimilar: DENOSUMAB-DSSB — FDA approvalOct 29, 2025
- approvalinfliximab biosimilar: RENFLEXIS (INFLIXIMAB-ABDA) — FDA approvalOct 28, 2025
comments(0)
5-min edit window · permanent after that